Agappe Diagnostics

Founded in 1997 and headquartered in Lucerne, Switzerland, Agappe Diagnostics is a private, commercial-stage company operating in the diagnostics sector. It has established itself as a manufacturer of laboratory analyzers and reagents, targeting the need for affordable diagnostic solutions in both developed and emerging markets. The company's business model is centered on the sale of instruments and recurring revenue from consumable reagents. As a private entity, its financial details and specific leadership are not publicly disclosed, but its long operational history suggests a stable, revenue-generating position within the competitive IVD landscape.

Manufacturer of clinical chemistry and immunoassay analyzers and corresponding liquid-ready-to-use reagents, focusing on affordability and reliability for clinical laboratories.

Agappe operates in the highly competitive global IVD market, competing directly with multinational giants like Roche, Abbott, Siemens Healthineers, and Danaher (Beckman Coulter), as well as other mid-tier and low-cost manufacturers. Its primary competitive differentiation is price and value for essential chemistry and immunoassay tests.